Manufacturing, Gene Therapies

Corning’s New Cell and Gene Therapy Platform Demonstrates Large-Scale Bioproduction

August 19, 2021

Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.

AGC Biologics Acquires Cell and Gene Therapy Commercial Manufacturing Facility

August 09, 2021

AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.

University of Sheffield and CGT Catapult Launch Innovative Gene Therapy Program

August 04, 2021

The University of Sheffield has launched an innovative gene therapy program that could pave the way for novel treatments for neurodegenerative diseases.

PerkinElmer to Acquire BioLegend in $5.25-Billion Deal

July 27, 2021

PerkinElmer has entered into an agreement to acquire BioLegend, a global developer and manufacturer, in a deal valued at $5.25 billion.

Pall Enters Multi-Million Dollar Contract with Exothera for Viral Vector Manufacturing

July 21, 2021

Pall has secured a manufacturing contract with Exothera for the suspension-based manufacture of gene therapies and viral vector-based vaccines.

Kriya Therapeutics to Advance Gene Therapies with $100 Million Financing

July 16, 2021

Kriya Therapeutics completes $100 Million Series B financing to advance its platform for designing, developing, and manufacturing gene therapies.

Custom Viral Vector Manufacturing Protocols to be Produced by Univercells Technologies and VectorBuilder

July 09, 2021

Univercells Technologies and VectorBuilder to produce custom viral vectors for cell and gene therapies as well as vaccine applications.

Thermo Fisher Expands Gene Therapy Portfolio to Support AAV Manufacturing

July 08, 2021

A new media panel, gene kit, and advanced resins that are now in Thermo Fisher Scientific’s gene therapy portfolio aim to reduce manufacturing costs and increase gene therapy viability.

Analytical Strategies for Cell and Gene Therapy Development

July 01, 2021

Developing bioassay methods requires a new approach for cell and gene therapy drug development.

Yposkesi’s Bioproduction Project Selected for French Government Investment

June 30, 2021

CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.